文献速递腹部MR

肝纤维化与脂肪肝对T1rho测量值的影响:一项前瞻性研究

Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study.
PubMed 文献 · Korean J Radiol · 2017-09-21

这项前瞻性研究纳入18名健康者、18例脂肪肝患者和18例肝纤维化患者,比较三组肝脏T1rho、PDFF和T2*值。肝纤维化组平均T1rho值(52.6±6.8 ms)显著高于健康组(44.9±2.8 ms)和脂肪肝组(45.0±3.5 ms),而后两组间无显著差异;T1rho检测肝纤维化的AUC为0.855(阈值49.5 ms)。结论认为T1rho MRI有助于无创检测肝纤维化,且可能不受脂肪肝影响。

要点

  • 肝纤维化组平均T1rho值52.6±6.8 ms,显著高于健康组44.9±2.8 ms和脂肪肝组45.0±3.5 ms。
  • 健康组与脂肪肝组平均T1rho值无显著差异(p=0.999)。
  • T1rho检测肝纤维化阈值49.5 ms时AUC为0.855,与肝硬度中度相关(r=0.671,p=0.012)。

核心结论

  • T1rho MRI有助于无创检测肝纤维化,且可能不受脂肪肝存在的影响。

研究设计与样本

  • 前瞻性研究,纳入18名健康受试者、18例脂肪肝患者和18例肝纤维化患者,均行T1rho MRI和mDIXON采集,测量肝脏T1rho、PDFF和T2*值。

关键影像表现/征象

  • 肝纤维化组平均T1rho值52.6±6.8 ms,显著高于健康组44.9±2.8 ms(p<0.001)和脂肪肝组45.0±3.5 ms(p<0.001)。
  • 健康组与脂肪肝组平均T1rho值无显著差异(p=0.999)。
  • 脂肪肝组PDFF值16.07±10.59%,显著高于健康组1.43±1.36%(p<0.001)和纤维化组1.07±1.06%(p<0.001)。
  • 健康组与纤维化组PDFF值无显著差异(p=0.984)。
  • 三组间T2*值无显著差异(p=0.766)。

诊断标准与关键数值

  • T1rho检测肝纤维化的阈值为49.5 ms,AUC为0.855。
  • 平均T1rho值与肝硬度中度相关(r=0.671,p=0.012),与PDFF、T2*值、年龄或体重指数无相关性(p>0.05)。

临床应用与阅片要点

  • 肝脏T1rho值在肝纤维化组升高,健康组与脂肪肝组相似,脂肪肝可能不影响T1rho测量。
  • T1rho值与PDFF、T2*值、年龄及体重指数无相关性,阅片时可结合这些参数综合评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the liver T1rho values for detecting fibrosis, and the potential impact of fatty liver on T1rho measurements.

MATERIALS AND METHODS: This study included 18 healthy subjects, 18 patients with fatty liver, and 18 patients with liver fibrosis, who underwent T1rho MRI and mDIXON collections. Liver T1rho, proton density fat fraction (PDFF) and T2* values were measured and compared among the three groups. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the T1rho values for detecting liver fibrosis. Liver T1rho values were correlated with PDFF, T2* values and clinical data.

RESULTS: Liver T1rho and PDFF values were significantly different (p < 0.001), whereas the T2* (p = 0.766) values were similar, among the three groups. Mean liver T1rho values in the fibrotic group (52.6 ± 6.8 ms) were significantly higher than those of healthy subjects (44.9 ± 2.8 ms, p < 0.001) and fatty liver group (45.0 ± 3.5 ms, p < 0.001). Mean liver T1rho values were similar between healthy subjects and fatty liver group (p = 0.999). PDFF values in the fatty liver group (16.07 ± 10.59%) were significantly higher than those of healthy subjects (1.43 ± 1.36%, p < 0.001) and fibrosis group (1.07 ± 1.06%, p < 0.001). PDFF values were similar in healthy subjects and fibrosis group (p = 0.984). Mean T1rho values performed well to detect fibrosis at a threshold of 49.5 ms (area under the ROC curve, 0.855), had a moderate correlation with liver stiffness (r = 0.671, p = 0.012), and no correlation with PDFF, T2* values, subject age, or body mass index (p > 0.05).

CONCLUSION: T1rho MRI is useful for noninvasive detection of liver fibrosis, and may not be affected with the presence of fatty liver.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Xie S, Li Q, Cheng Y, et al. Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study. Korean J Radiol. 2017. PMID: 29089822. doi:10.3348/kjr.2017.18.6.898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。